Molecular Technologist III - JPC

• The incumbent coordinates and conducts all aspects of molecular testing focusing on nucleic acid (DNA/RNA) extraction, polymerase chain reaction (PCR) and Next Generation Sequencing (NGS) assays.
• The incumbent will monitor quality assurance metrics throughout the pre-analytical, analytical and post-analytical phases of testing to evaluate trends in specimen quality, specimen processing, specimen evaluation and specimen reporting, so as to provide an early indication of problems that may adversely affect the accuracy of the test results.
• The incumbent will design the laboratory to function in full accordance with accreditation standards established by the College of American Pathologists (CAP) and the DoW Clinical Laboratory Improvement Program (CLIP). This involves regular monitoring of CAP and CLIP accreditation requirements to make sure the laboratory's procedures and practices are in compliance with all accreditation standards. The incumbent is responsible for monitoring trends and medical breakthroughs that may apply to routine clinical practice and then incorporating those discoveries into the lab at the instruction of the Medical Director.
• The incumbent identifies training needs and arranges or conducts in-service training. They provide technical guidance, instruction, and consultation to faculty, students, and house-staff members (interns and residents) as assigned to include training of new personnel. Under the guidance of the Pathology Residency Program Director, the incumbent contributes to the curriculum and develops assessment tools while adapting current education philosophy techniques into the program of instruction. The incumbent is personally responsible for attaining and maintaining all relevant technical competencies and certifications to meet the standards for molecular technologists as outlined by the College of American Pathologists (CAP) and the DoW Clinical Laboratory Improvement Program (CLIP).
• The incumbent performs complex and highly exacting technical work that involves preparing human biological material for specialized molecular genetic analysis. Molecular testing requires strict adherence to, and development of, methods to prevent cross-contamination of DNA/RNA from the environment and other specimens that could result in an erroneous diagnosis of a genetic abnormality. The molecular technologist assesses new instruments for implementation and may develop or modify procedures for new molecular tests that may or may not have Food and Drug Administration (FDA) approval. In developing new tests, they analyze and correct errors resulting in spurious or unacceptable test results prior to implementation:
• The incumbent reviews clinical reports and records for trends and recommend policy changes based on review findings. They establish and maintain contacts with other Federal and State agencies, accrediting organizations, professional organizations and other agencies to keep abreast of new developments, obtain services and coordinate mutually beneficial projects. The incumbent maintains technical expertise and serves as a technical consultant for the Molecular Pathology service. They interpret agency policies and directives, prepare guidelines for laboratory operations, and advise the Medical Director on the maintenance, review and revision of procedure manuals.
• May perform other duties and responsibilities as assigned or directed by the supervisor. This may include attendance of and participation in required trainings and Lab Leadership meetings.

Join the HJF Team!

HJF is seeking a Molecular Technologist III for the John P. Murtha Cancer Center Research Program (MCCRP) to support the Joint Pathology Center (JPC) at Walter Reed National Military Medical Center in Bethesda, Maryland. U.S. Citizenship required.

The John P. Murtha Cancer Center at Walter Reed Bethesda is a modern, patient-centric, tri-service military healthcare facility. Its comprehensive core of military and civilian oncologists and other cancer-trained clinicians and researchers provide multidisciplinary cancer-care delivery and patient-family support services. Our Cancer Center, the only DoW Cancer Center of Excellence within the Military Health System, offers its patients access to cutting-edge cancer diagnostic and treatment technologies.

The Molecular Technologist III coordinates and conducts all pre-analytical, analytical and post-analytical aspects of complex technical work involved in preparing and interpreting human biological material for specialized molecular genetic analysis. Work involves development, verification, validation and testing molecular sequencing systems and applies broad knowledge and hands-on experience in such disciplines as molecular biology, molecular pathology, and biostatistics. Skill and experience in next-generation sequencing (NGS) platforms is required. Also, as per DoW Clinical Laboratory Improvement Program requirements, MB(ASCP) or SMB(ASCP) certification is required for this position. The position requires experience and demonstrated capability in standard molecular biological techniques, e.g., isolation of nucleic acids from various clinical specimens (blood, body fluids and tissue), polymerase chain reaction (PCR) as well as standard biochemical techniques, e.g., centrifugation and electrophoresis. The position requires working with hazardous human biological materials (tissue, blood and body fluids). Knowledge and skills for implementation of a completely electronic format for collecting, reporting and storage of laboratory data using Laboratory Information Management System (LIMS) is critical. Responsibilities may also include reporting results in scientific literature, presentations at national and international meetings, and preparation of command and agency briefings.

The Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF) is a nonprofit organization dedicated to advancing military medicine. We serve military, medical, academic and government clients by administering, managing and supporting preeminent scientific programs that benefit members of the armed forces and civilians alike. Since its founding in 1983, HJF has served as a vital link between the military medical community and its federal and private partners. HJF's support and administrative capabilities allow military medical researchers and clinicians to maintain their scientific focus and accomplish their research goals.